Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-41553
Ungerer, C; Doberstein, K; Bürger, C; Hardt, K; Boehncke, W H; Böhm, B; Pfeilschifter, J; Dummer, R; Mihic-Probst, D; Gutwein, P (2010). ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma. Biochemical and Biophysical Research Communications (BBRC), 401(3):363-369.
|PDF (Verlags-PDF) - Registered users only|
In a mouse melanoma metastasis model it has been recently shown that ADAM15 overexpression in melanoma cells significantly reduced the number of metastatic nodules on the lung. Unfortunately, the expression of ADAM15 in human melanoma tissue has not been determined so far. In our study, we characterized the expression of ADAM15 in tissue micro-arrays of patients with primary melanoma with melanoma metastasis. ADAM15 was expressed in melanocytes and endothelial cells of benign nevi and melanoma tissue. Importantly, ADAM15 was significantly downregulated in melanoma metastasis compared to primary melanoma. We further demonstrate that IFN-γ and TGF-β downregulate ADAM15 protein levels in melanoma cells. To investigate the role of ADAM15 in melanoma progression, we overexpressed ADAM15 in melanoma cells. Importantly, overexpression of ADAM15 in melanoma cells reduced the migration, invasion and the anchorage dependent and independent cell growth of melanoma cells. In summary, the downregulation of ADAM15 plays an important role in melanoma progression and ADAM15 act as a tumorsuppressor in melanoma.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Institute of Surgical Pathology|
04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
|DDC:||610 Medicine & health|
|Deposited On:||07 Jan 2011 13:40|
|Last Modified:||27 Nov 2013 20:16|
|Citations:||Web of Science®. Times cited: 5|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page